Skip to main content
NCBI home page
Current Therapeutic Research, Clinical and Experimental logoLink to Current Therapeutic Research, Clinical and Experimental
. 2006 Sep;67(5):334–349. doi: 10.1016/j.curtheres.2006.10.004

Effects of a 250-mL enema containing sodium phosphate on electrolyte concentrations in healthy volunteers: An open-label, randomized, controlled, two-period, crossover clinical trial*

Belén Sédaba 1,**, Josh R Azanza 1, Miguel A Campanero 1, Emilio Garcia-Quetglas 1, Maria Josh Muñoz 1, Santiago Marco 2
PMCID: PMC3965995  PMID: 24678106

Abstract

Background:

Enemas are used by individuals with constipation and are often required before certain medical diagnostic procedures and surgical interventions. However, abnormalities in serum electrolyte concentrations have been associated with enema use.

Objective:

The aim of this study was to determine the changes in serum electrolyte concentrations (phosphorus, calcium, sodium, and potassium) and urinary phosphorus elimination after the administration of a sodium phosphate enema.

Methods:

Healthy volunteers aged 35 to 70 years were eligible for this open-label, randomized, controlled, 2-period, crossover clinical trial at the Clinical Research Unit of the University Hospital of Navarra, Pamplona, Spain. The study comprised 2 one-day periods separated by a 7-day washout. All subjects were randomly assigned in a 1:1 ratio to 1 of 2 study sequences: (1) a single dose of Enema Casen® 250 mL in the first period followed by no treatment (control) in the second period, or (2) no treatment in the first period followed by a single dose of the study drug in the second period. The sequence of treatment was assigned using a randomization table that was prepared before the beginning of the study. Serum concentrations of phosphorus, sodium, potassium, and calcium were measured in both periods. Urinary phosphorus elimination was measured for 12 hours after enema administration (Ae0–12) in a subset of the subjects in the second period. Adverse events (AEs) were monitored by the investigators throughout the study. Normal ranges for the electrolytes were as follows: phosphorus, 2.5 to 5 mg/dL; calcium, 8.5 to 10.5 mg/dL; sodium, 135 to 145 mEq/L; and potassium, 3.5 to 5 mEq/L.

Results:

Twenty-four subjects (12 men, 12 women; mean [SD] age, 47.8 [9.6] years [range, 36–68 years]) participated in the study. All of the subjects were white and none were smokers. Twelve hours after enema administration, mean serum phosphorus and sodium concentrations increased by a mean of 1.18 mg/dL and 1.32 mEq/L, respectively (both, P < 0.001). Mean serum phosphorus concentrations were above the upper limit of normal (5 mg/dL) at 30 and 60 minutes after enema administration. In all subjects the values returned to normal within 4 hours after enema administration; a meal was provided after a 3-hour fast. Four subjects (16.7%) had ≥1 serum phosphorus concentration measurement ≥7 mg/dL, a value that is considered serious hyperphosphatemia. A statistically significant correlation was found between phosphorus Cmax and enema retention time (r2 = 0.452; P < 0.001). No abnormal serum concentrations were obtained for the other electrolytes measured. Phosphorus Ae0–12 was increased after enema administration by 86% (P < 0.001). No serious AEs were observed, although 13 AEs were reported in 9 subjects. None of the changes in serum electrolyte concentrations were associated with clinical symptoms.

Conclusions:

Administration of an enema containing 250 mL of sodium phosphate was associated with serum phosphorus concentrations of ≥7 mg/dL in 16.7% of the healthy subjects who participated in the study; however, none of those subjects experienced hypocalcemia. Enema retention time was significantly correlated with the degree of phosphatemia.

Key words: phosphatemia, electrolyte modifications, sodium phosphate enema, phosphaturia, absorption

Full Text

The Full Text of this article is available as a PDF (903.2 KB).

Footnotes

*

This study was presented in part as an abstract at the XIXth Spanish Clinical Pharmacology Society (Sociedad Española de Farmacología Clínica-SEFC), October 27-30, 2004, Santander, Spain.

References

  • 1.Martinez Velasco M.C., Ahmad al Ghool M., Sos Ortigosa F., Bengoechea Barcala C. Acute hyperphosphatemia induced by enemas [in Spanish] Med Clin (Barc). 1998;110:805. [PubMed] [Google Scholar]
  • 2.Enema Casen [package insert] Laboratorios Casen Fleet S.L.; Zaragoza, Spain: 2004. [Google Scholar]
  • 3.Shiber J.R., Mattu A. Serum phosphate abnormalities in the emergency department. J Emerg Med. 2002;23:395–400. doi: 10.1016/s0736-4679(02)00578-4. [DOI] [PubMed] [Google Scholar]
  • 4.Cohan C.F., Kadakia S.C., Kadakia A.S. Serum electrolyte, mineral, and blood pH changes after phosphate enema, water enema, and electrolyte lavage solution enema for flexible sigmoidoscopy. Gastrointest Endosc. 1992;38:575–578. doi: 10.1016/s0016-5107(92)70520-3. [DOI] [PubMed] [Google Scholar]
  • 5.Gutierrez-Santiago M., Garcia-Unzueta M., Amado J.A. Electrolyte disorders following colonic cleansing for imaging studies [in Spanish] Med Clin (Barc) 2006;126:161–164. doi: 10.1157/13084533. [DOI] [PubMed] [Google Scholar]
  • 6.Ainley E.J., Winwood P.J., Begley J.P. Measurement of serum electrolytes and phosphate after sodium phosphate colonoscopy bowel preparation: An evaluation. Dig Dis Sci. 2005;50:1319–1323. doi: 10.1007/s10620-005-2780-9. [DOI] [PubMed] [Google Scholar]
  • 7.Ell C., Fischbach W., Keller R., Hintertux Study Group A randomized, blinded, prospective trial to compare the safety and efficacy of three bowel-cleansing solutions for colonoscopy (HSG-01*) Endoscopy. 2003;35:300–304. doi: 10.1055/s-2003-38150. [DOI] [PubMed] [Google Scholar]
  • 8.Seinela L., Pehkonen E., Laasanen T., Ahvenainen J. Bowel preparation for colonoscopy in very old patients: A randomized prospective trial comparing oral sodium phosphate and polyethylene glycol electrolyte lavage solution. Scand J Gastroenterol. 2003;38:216–220. [PubMed] [Google Scholar]
  • 9.Poon C.M., Lee D.W., Mak S.K. Two liters of polyethylene glycol-electrolyte lavage solution versus sodium phosphate as bowel cleansing regimen for colonoscopy: A prospective randomized controlled trial. Endoscopy. 2002;34:560–563. doi: 10.1055/s-2002-33207. [DOI] [PubMed] [Google Scholar]
  • 10.Mathus-Vliegen E.M., Kemble U.M. A prospective randomized blinded comparison of sodium phosphate and polyethylene glycol-electrolyte solution for safe bowel cleansing. Aliment Pharmacol Ther. 2006;23:543–552. doi: 10.1111/j.1365-2036.2006.02777.x. [DOI] [PubMed] [Google Scholar]
  • 11.World Medical Association Declaration of Helsinki . WMA; Ferney-Voltaire, France: 1989. Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects [WMA Web site]http://www.wma.net Available at: Accessed June 18, 2004. [Google Scholar]
  • 12.European Agency for the Evaluation of Medicinal Products . International Conference on Harmonisation-World Health Organization. Guideline for Good Clinical Practice [EMEA Web site]. ICH Topic E6. WHO; Geneva, Switzerland: 2002. http://www.emea.eu.int Available at: Accessed June 18, 2004. [Google Scholar]
  • 13.Calcio Arsenazo., III . 2006. Colorimetric [in Spanish]http://www.spinreact.com/uploads/pdf/BSDTT09%20CALCIUM-A%20III.pdf Available at: Accessed October 13. [Google Scholar]
  • 14.Fosforo. Fosfomobildato. Colorimetric [in Spanish] 2006. http://wwwspinreact.com/uploads/pdf/BSDTT15%20PHOSPHORUS%20-UVpdf [Google Scholar]
  • 15.Karch F.E., Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther. 1977;21:247–254. doi: 10.1002/cpt1977213247. [DOI] [PubMed] [Google Scholar]
  • 16.Gumurdulu Y., Serin E., Ozer B. Age as a predictor of hyperphosphatemia after oral phosphosoda administration for colon preparation. J Gastroenterol Hepatol. 2004;19:68–72. doi: 10.1111/j.1440-1746.2004.03253.x. [DOI] [PubMed] [Google Scholar]
  • 17.Curran M.P., Plosker G.L. Oral sodium phosphate solution: A review of its use as a colorectal cleanser. Drugs. 2004;64:1697–1714. doi: 10.2165/00003495-200464150-00009. [DOI] [PubMed] [Google Scholar]
  • 18.Tan H.L., Liew Q.Y., Loo S., Hawkins R. Severe hyperphosphataemia and associated electrolyte and metabolic derangement following the administration of sodium phosphate for bowel preparation. Anaesthesia. 2002;57:478–483. doi: 10.1046/j.0003-2409.2001.02519.x. [DOI] [PubMed] [Google Scholar]
  • 19.van Hoogdalem E.J., de Boer A.G., Brenner D.D. Pharmacokinetics of rectal drug administration, part II. Clinical applications of peripherally acting drugs, and conclusions. Clin Pharmacokinet. 1991;21:110–128. doi: 10.2165/00003088-199121020-00003. [DOI] [PubMed] [Google Scholar]
  • 20.Schuchmann G.D., Barcia P.J. Phosphate absorption from fleet enemas in adults. Curr Surg. 1989;46:120–122. [PubMed] [Google Scholar]
  • 21.Gutierrez E., Gonzalez E., Hernandez E. Acute hyperphosphatemia secondary to phosphate administration for bowel preparation [in Spanish] Nefrologia. 2004;24:283–287. [PubMed] [Google Scholar]
  • 22.Grosskopf I., Graff E., Charach G. Hyperphosphataemia and hypocalcaemia induced by hypertonic phosphate enema-an experimental study and review of the literature. Hum Exp Toxicol. 1991;10:351–355. doi: 10.1177/096032719101000509. [DOI] [PubMed] [Google Scholar]
  • 23.Marin Gabriel J.C., Rodriguez Munoz S., de la Cruz Bertolo J. Electrolytic disturbances and colonoscopy: Bowel lavage solutions, age and procedure. Rev Esp Enferm Dig. 2003;95:863–875. [PubMed] [Google Scholar]
  • 24.Nir-Paz R., Cohen R., Haviv Y.S. Acute hyperphosphatemia caused by sodium phosphate enema in a patient with liver dysfunction and chronic renal failure. Ren Fail. 1999;21:541–544. doi: 10.3109/08860229909045194. [DOI] [PubMed] [Google Scholar]
  • 25.Soumoy M.P., Bachy A. Risk of phosphate enemas in the infant [in French] Arch Pediatr. 1998;5:1221–1223. doi: 10.1016/s0929-693x(98)81238-4. [DOI] [PubMed] [Google Scholar]
  • 26.Helikson M.A., Parham W.A., Tobias J.D. Hypocalcemia and hyperphosphatemia after phosphate enema use in a child. J Pediatr Surg. 1997;32:1244–1246. doi: 10.1016/s0022-3468(97)90692-8. [DOI] [PubMed] [Google Scholar]
  • 27.Ehrenpreis E.D., Wieland J.M., Cabral J. Symptomatic hypocalcemia, hypomagnesemia, and hyperphosphatemia secondary to Fleet's Phospho-Soda colonoscopy preparation in a patient with a jejunoileal bypass. Dig Dis Sci. 1997;42:858–860. doi: 10.1023/a:1018840920092. [DOI] [PubMed] [Google Scholar]
  • 28.Sutters M., Gaboury C.L., Bennett W.M. Severe hyperphosphatemia and hypocalcemia: A dilemma in patient management. J Am Soc Nephrol. 1996;7:2056–2061. [PubMed] [Google Scholar]
  • 29.Wilmanns C., Bernschneider T., Schoffel U., Farthmann E.H. Enema-induced hyperphosphatemia in ileus of the small and large intestine [in German] Zentralbl Chir. 1995;120:981–983. [PubMed] [Google Scholar]
  • 30.Fass R., Do S., Hixson L.J. Fatal hyperphosphatemia following Fleet Phospo-Soda in a patient with colonic ileus. Am J Gastroenterol. 1993;88:929–932. [PubMed] [Google Scholar]
  • 31.Korzets A., Dicker D., Chaimoff C., Zevin D. Life-threatening hyperphosphatemia and hypocalcemic tetany following the use of fleet enemas. J Am Geriatr Soc. 1992;40:620–621. doi: 10.1111/j.1532-5415.1992.tb02115.x. [DOI] [PubMed] [Google Scholar]
  • 32.Wason S., Tiller T., Cunha C. Severe hyperphosphatemia, hypocalcemia, acidosis, and shock in a 5-month-old child following the administration of an adult Fleet enema. Ann Emerg Med. 1989;18:696–700. doi: 10.1016/s0196-0644(89)80533-5. [DOI] [PubMed] [Google Scholar]
  • 33.Biberstein M., Parker B.A. Enema-induced hyperphosphatemia. Am J Med. 1985;79:645–646. doi: 10.1016/0002-9343(85)90064-6. [DOI] [PubMed] [Google Scholar]
  • 34.Rohack J.J., Mehta B.R., Subramanyam K. Hyperphosphatemia and hypocalcemic coma associated with phosphate enema. South Med J. 1985;78:1241–1242. doi: 10.1097/00007611-198510000-00023. [DOI] [PubMed] [Google Scholar]
  • 35.Reedy J.C., Zwiren G.T. Enema-induced hypocalcemia and hyperphosphatemia leading to cardiac arrest during induction of anesthesia in an outpatient surgery center. Anesthesiology. 1983;59:578–579. doi: 10.1097/00000542-198312000-00020. [DOI] [PubMed] [Google Scholar]
  • 36.Haldimann B., Vogt K. Hyperphosphatemia and tetany following phosphate enema [in French] Schweiz Med Wochenschr. 1983;113:1231–1233. [PubMed] [Google Scholar]
  • 37.Sotos J.F., Cutler E.A., Finkel M.A., Doody D. Hypocalcemic coma following two pediatric phosphate enemas. Pediatrics. 1977;60:305–307. [PubMed] [Google Scholar]
  • 38.Davis R.F., Eichner J.M., Bleyer W.A., Okamoto G. Hypocalcemia, hyperphosphatemia, and dehydration following a single hypertonic phosphate enema. J Pediatr. 1977;90:484–485. doi: 10.1016/s0022-3476(77)80723-3. [DOI] [PubMed] [Google Scholar]
  • 39.Martin R.R., Lisehora G.R., Braxton M., Jr, Barcia P.J. Fatal poisoning from sodium phosphate enema. Case report and experimental study. JAMA. 1987;257:2190–2192. [PubMed] [Google Scholar]
  • 40.Ma K.K., Ng C.S., Mui L.M. Severe hyperphosphatemia and hypocalcemia following sodium phosphate bowel preparation: A forgotten menace. Endoscopy. 2003;35:717. doi: 10.1055/s-2003-41507. [DOI] [PubMed] [Google Scholar]

Articles from Current Therapeutic Research, Clinical and Experimental are provided here courtesy of Elsevier

RESOURCES